Views

View Apr 17, 2023

FTC Compliance Warning for Product Health Claims

View Apr 11, 2023

Cosmetics Industry Regulatory Updates

View Mar 22, 2023

Is Patient Engagement in Regulatory Decisions at a Tipping Point?

View Mar 15, 2023

The Target Product Profile: A Foundation for Patient Impact and Commercial Success

View Mar 7, 2023

HTA Reforms in Germany

View Feb 27, 2023

Journey to Insight and Inspiration

View Feb 24, 2023

Weathering the Storm: Portfolio Diversification Strategies to Ensure Life-saving Advanced Therapeutics Reach Rare Disease Patients Amidst the Market Downturn

View Feb 23, 2023

Unsure About the EU HTA Regulation?

View Feb 14, 2023

Inflation Reduction Act and Maximum Fair Price: Possible Industry and Practice Impacts

View Feb 9, 2023

Fundraising in 2023: The Post JP Morgan/Biotech Showcase Outlook For Early-Stage Companies

View Feb 6, 2023

Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 3)

View Jan 20, 2023

Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 2)

Market Structure

View Jan 18, 2023

The Importance of Engaging Patients and Patient Advocates Throughout the Medicine Development Cycle

View Jan 9, 2023

Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 1)

View Jan 3, 2023

Small Biotechs Versus Large Pharma: Who Drives First-in-class Innovation in Oncology?

View Dec 22, 2022

Can Digital Technologies Improve Oncology Care?

1 … 15 16 17 18 19 … 25